The execution of new guidelines for the management of breast implant surgeries in Australia to protect the patients from risks that may trigger due to perilous practices and ‘carelessly performed’ surgeries is expected to drive the breast implant market, says GlobalData, a leading data and analytics company.

GlobalData’s latest report, ‘Aesthetic Implants Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030’, reveals that the breast implants market accounted for around 85% of Australia’s aesthetic implants market in 2021.

With the implementation of new guidelines published by the New South Wales Ministry of Health, it will be made mandatory for doctors to follow certain standards of care while and after performing the breast implant surgery.

Anusha Kaushik, Medical Devices Analyst at GlobalData, comments: “The guidelines clearly state how doctors or medical professionals should perform their work while being transparent about the breast implant procedure, side effects, or any other risks associated with the procedure and the patients. Discussing the available treatment options and the associated risks will help patients to take the best possible decision about their health.”

Along with the newly released guidelines, increase in the number of breast reconstruction and augmentation procedures are expected to boost Australia’s breast implant market in the coming years.

Kaushik concludes: “These new guidelines, though tough for some surgeons to follow, are aimed at changing the way breast implant procedures are managed. This is expected to further drive the breast implants market in Australia by improving transparency and enhancing patient safety. However, the need for more specialized training and increase in the overhead costs these procedures may hamper the growth of this market.”